Liquid Dosage

Inhalable Suspension

Inhalation is often the preferred drug delivery method for lung diseases, offering a number of advantages for both patients and medical professionals for the administration of vaccines and other biological drugs.

The active ingredient of many inhalable products, such as anti-asthma medications, acts on the muscle cells of the pulmonary airways. Such medications can be rendered inefficient, however, if particles aggregate in the inhaler. In addition, to prevent dry powder aerosols from depositing particulate matter in the oropharyngeal cavity — and in the inhaler — dispensed particles should have a geometric diameter of 1–3 µm and a mass density of approximately 1 g/cm3.

Inhaled drugs are usually dissolved in an aqueous system, such as an isotonic salt solution, and aerosolized at a high pressure to obtain nebulized particles. The liquid solution is pumped through a homogenizing valve at 500–1000 bar, using a single stage process, during which semi-solid particles become dispersed in the liquid.

The high-pressure homogenization enables the size reduction of average to large particles and makes the suspension more stable as a result of the decreased sedimentation rate. Moreover, it eliminates biological risk and provides better tolerance to irritants, as well as improving the clarity and transparency of the processed product.

In addition to a comprehensive range of homogenizers, GEA also offers production-scale mixing, blending, spray drying and micronization solutions for the manufacture of inhalable products, plus an unparalleled level of expertise in the design and layout of suitable plant: from vessel size dimensions to valves and 3D P&IDs, and from R&D to full-scale production.

Аналитика GEA

GEA helps dairy cows avoid lameness with AI solution

GEA minimizes dairy cow lameness with AI solution

GEA CattleEye alerts dairy farmers when cows are lame, enabling them to address health issues quickly to ensures optimal cow health and milk yield.

Clothes recycled by GEA

Решения GEA позволяют перерабатывать текстиль из волокна в волокно

Решения по химической переработке от GEA позволяют перерабатывать текстиль из смешанных волокон с ПЭТ и делать из него новую экологичную одежду.

Workers working at Hovione

Advancing continuous pharmaceutical manufacturing

GEA and partners innovate flexible continuous processing technologies, transforming pharmaceutical development and manufacturing for a modernized future.

Получайте новости от GEA

Будьте в курсе инноваций и историй GEA, подписавшись на новостную рассылку от GEA.

Связаться с нами

Мы всегда готовы помочь! Сообщите необходимые данные, и мы предоставим ответ.